BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25168922)

  • 1. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection.
    Qiao Y; Chen J; Li X; Wei H; Xiao F; Chang L; Zhang R; Hao X; Wei H
    Clin Biochem; 2014 Nov; 47(16-17):216-22. PubMed ID: 25168922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections.
    Wei H; Zhang J; Li H; Ren H; Hao X; Huang Y
    Diagn Microbiol Infect Dis; 2014 May; 79(1):19-24. PubMed ID: 24560809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of the serum hepatocellular carcinoma marker Golgi glycoprotein (GP73) among Qidong residents and correlation analysis to outcome at two-year follow-up].
    Chen JG; Zhu YR; Lu WZ; Zhang YH; Lu JH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):780-4. PubMed ID: 23207341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
    Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
    J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G; Dong F; Xu X; Hu A; Hu Y
    Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.
    Wei H; Li B; Zhang R; Hao X; Huang Y; Qiao Y; Hou J; Li X; Li X
    PLoS One; 2013; 8(2):e53862. PubMed ID: 23418424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
    Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.
    Xu Z; Shen J; Pan X; Wei M; Liu L; Wei K; Liu L; Yang H; Huang J
    J Med Virol; 2018 Jun; 90(6):1053-1062. PubMed ID: 29424455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.
    Hu JS; Wu DW; Liang S; Miao XY
    Med Oncol; 2010 Jun; 27(2):339-45. PubMed ID: 19399652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
    J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
    Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
    Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
    Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
    World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B.
    Xu Z; Pan X; Wei K; Ding H; Wei M; Yang H; Liu Q
    Mol Med Rep; 2015 Apr; 11(4):2644-52. PubMed ID: 25524053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.
    Xu Z; Liu L; Pan X; Wei K; Wei M; Liu L; Yang H; Liu Q
    Medicine (Baltimore); 2015 Mar; 94(12):e659. PubMed ID: 25816035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.